WallStreetZenWallStreetZen

NASDAQ: AMRN
Amarin Corp PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their AMRN stock forecasts and price targets.

Forecast return on equity

Is AMRN forecast to generate an efficient return?

Company
136.96%
Industry
10.09%
Market
178.03%
AMRN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AMRN forecast to generate an efficient return on assets?

Company
97.31%
Industry
28.93%
AMRN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AMRN earnings per share forecast

What is AMRN's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.03
Avg 2 year Forecast
-$0.02
Avg 3 year Forecast
-$0.04

AMRN revenue forecast

What is AMRN's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$175.0M-6.05%
Avg 2 year Forecast
$167.9M-9.83%
Avg 3 year Forecast
$161.1M-13.52%
AMRN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMRN revenue growth forecast

How is AMRN forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
-4.73%
Industry
8.34%
Market
13.78%
AMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMRN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AMRN$14.41N/AN/A
SCLX$6.52N/AN/A
NSRX$3.32$18.00+442.17%Buy
MIRA$0.66N/AN/A
MDCX$0.30$9.00+2,930.30%Strong Buy
View Top General Drug Manufacturer Stocks

Amarin Stock Forecast FAQ

What is AMRN's earnings growth forecast for 2026-2028?

(NASDAQ: AMRN) Amarin's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 32.03%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.36%.

Amarin's earnings in 2026 is -$27,124,000.On average, 3 Wall Street analysts forecast AMRN's earnings for 2026 to be -$12,927,175, with the lowest AMRN earnings forecast at -$12,420,227, and the highest AMRN earnings forecast at -$13,307,386. On average, 3 Wall Street analysts forecast AMRN's earnings for 2027 to be -$8,618,116, with the lowest AMRN earnings forecast at -$8,280,151, and the highest AMRN earnings forecast at -$8,871,590.

In 2028, AMRN is forecast to generate -$17,236,233 in earnings, with the lowest earnings forecast at -$16,560,302 and the highest earnings forecast at -$17,743,181.

If you're new to stock investing, here's how to buy Amarin stock.

What is AMRN's revenue growth forecast for 2026-2028?

(NASDAQ: AMRN) Amarin's forecast annual revenue growth rate of -4.73% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.

Amarin's revenue in 2026 is $186,232,000.On average, 3 Wall Street analysts forecast AMRN's revenue for 2026 to be $73,917,246,174, with the lowest AMRN revenue forecast at $71,019,193,315, and the highest AMRN revenue forecast at $76,088,673,535. On average, 3 Wall Street analysts forecast AMRN's revenue for 2027 to be $70,938,926,545, with the lowest AMRN revenue forecast at $68,159,161,558, and the highest AMRN revenue forecast at $73,025,862,569.

In 2028, AMRN is forecast to generate $68,036,649,119 in revenue, with the lowest revenue forecast at $65,370,947,437 and the highest revenue forecast at $70,039,093,806.

What is AMRN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: AMRN) forecast ROA is 97.31%, which is higher than the forecast US Drug Manufacturers - General industry average of 28.93%.

What is AMRN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AMRN) Amarin's current Earnings Per Share (EPS) is -$1.40. On average, analysts forecast that AMRN's EPS will be -$0.03 for 2026, with the lowest EPS forecast at -$0.03, and the highest EPS forecast at -$0.03. On average, analysts forecast that AMRN's EPS will be -$0.02 for 2027, with the lowest EPS forecast at -$0.02, and the highest EPS forecast at -$0.02. In 2028, AMRN's EPS is forecast to hit -$0.04 (min: -$0.04, max: -$0.04).

What is AMRN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: AMRN) forecast ROE is 136.96%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.